Crestline SI (GP), L.P.
CIK 1626597 · last filed 2021-02-17
Crestline SI (GP), L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider sold $720.5M of DNLI on Feb 17, 2021. Across all open-market trades the lifetime net is −$642.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.17M
2
2
-$642.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNLI | 10%+ Owner | 100,102 | $21.66 | $2.17M | -$720.46M | 1 | 2021-02-17 |
| Juno Therapeutics, Inc. (JUNO) Delisted | 10%+ Owner | 23,488,398 | — | — | $78.12M | 1 | 2014-12-23 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-17 | DNLI | Sell (S) | −11,083,990 | -$720.46M | EDGAR |
| 2014-12-23 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | +133,605,635 | $78.12M | EDGAR |